US2143590A
(en)
|
1936-09-26 |
1939-01-10 |
Univ Alberta |
Insulin preparation and process of producing crystals of insulin
|
US2626228A
(en)
|
1945-05-17 |
1953-01-20 |
Novo Terapeutisk Labor As |
Method of producing crystalline insulin
|
US2819999A
(en)
|
1953-11-13 |
1958-01-14 |
Novo Terapeutisk Labor As |
Process for crystallization of insulin using freeze dried insulin as seeding material
|
US3649456A
(en)
|
1969-09-08 |
1972-03-14 |
Rohm & Haas |
Separation of polypeptide substances with macroreticular resins
|
US3683635A
(en)
|
1970-12-07 |
1972-08-15 |
Mario Campanelli |
Freeze stabilized insulin
|
FR2224175B1
(sl)
|
1973-04-04 |
1978-04-14 |
Isf Spa |
|
GB1479283A
(en)
|
1973-07-23 |
1977-07-13 |
Bespak Industries Ltd |
Inhaler for powdered medicament
|
US4153689A
(en)
|
1975-06-13 |
1979-05-08 |
Takeda Chemical Industries, Ltd. |
Stable insulin preparation for nasal administration
|
DE2629568C3
(de)
|
1976-07-01 |
1981-09-10 |
Hoechst Ag, 6000 Frankfurt |
Verfahren zur Reinigung von Insulin, seinen Analogen und Derivaten
|
US4211769A
(en)
|
1977-08-24 |
1980-07-08 |
Takeda Chemical Industries, Ltd. |
Preparations for vaginal administration
|
US4377482A
(en)
|
1978-04-28 |
1983-03-22 |
Salk Institute For Biological Studies |
Mobile phase for liquid chromatography
|
US4196196A
(en)
|
1978-06-19 |
1980-04-01 |
Tiholiz Ivan C |
Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states
|
US4272398A
(en)
|
1978-08-17 |
1981-06-09 |
The United States Of America As Represented By The Secretary Of Agriculture |
Microencapsulation process
|
JPS55138393A
(en)
*
|
1979-04-13 |
1980-10-29 |
Shionogi & Co Ltd |
Semisynthesis of insulin
|
JPS6034925B2
(ja)
|
1979-07-31 |
1985-08-12 |
帝人株式会社 |
持続性鼻腔用製剤およびその製造法
|
US4343898A
(en)
|
1980-02-11 |
1982-08-10 |
Novo Industri A/S |
Process for preparing esters of human insulin
|
DK147437A
(en)
|
1980-02-11 |
1900-01-01 |
|
Process for preparing human insulin or threonine B30 esters of human insulin, or a salt or complex thereof
|
US4364385A
(en)
|
1981-03-13 |
1982-12-21 |
Lossef Steven V |
Insulin delivery device
|
ATE23272T1
(de)
|
1981-07-08 |
1986-11-15 |
Draco Ab |
Pulverinhalator.
|
JPS58501125A
(ja)
|
1981-07-17 |
1983-07-14 |
ノルデイスク・インスリンラボラトリウム |
安定な水性治療性インシユリン製剤及びその製造方法
|
US5260306A
(en)
|
1981-07-24 |
1993-11-09 |
Fisons Plc |
Inhalation pharmaceuticals
|
DK353781A
(da)
|
1981-08-10 |
1983-02-11 |
Novo Industri As |
Fremgangsmaade til fremstilling af insulinderivater
|
KR890000664B1
(ko)
*
|
1981-10-19 |
1989-03-22 |
바리 안소니 뉴우샘 |
미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
|
FI78616C
(fi)
|
1982-02-05 |
1989-09-11 |
Novo Industri As |
Foerfarande foer framstaellning av en foer infusionsaendamaol avsedd stabiliserad insulinloesning, som har en foerhoejd zinkhalt.
|
US4459226A
(en)
|
1982-02-26 |
1984-07-10 |
Eli Lilly And Company |
Process for recovering insulin
|
US4659696A
(en)
*
|
1982-04-30 |
1987-04-21 |
Takeda Chemical Industries, Ltd. |
Pharmaceutical composition and its nasal or vaginal use
|
JPS59163313A
(ja)
|
1983-03-09 |
1984-09-14 |
Teijin Ltd |
経鼻投与用ペプチドホルモン類組成物
|
WO1995013796A1
(en)
|
1993-11-16 |
1995-05-26 |
Depotech Corporation |
Vesicles with controlled release of actives
|
US4946828A
(en)
*
|
1985-03-12 |
1990-08-07 |
Novo Nordisk A/S |
Novel insulin peptides
|
US5785989A
(en)
*
|
1985-05-01 |
1998-07-28 |
University Utah Research Foundation |
Compositions and methods of manufacturing of oral dissolvable medicaments
|
PT83613B
(en)
|
1985-10-28 |
1988-11-21 |
Lilly Co Eli |
Process for the selective chemical removal of a protein amino-terminal residue
|
SE453566B
(sv)
|
1986-03-07 |
1988-02-15 |
Draco Ab |
Anordning vid pulverinhalatorer
|
JPS6320301A
(ja)
|
1986-07-11 |
1988-01-28 |
Dainichi Color & Chem Mfg Co Ltd |
キトサン微小粒体
|
US5042975A
(en)
*
|
1986-07-25 |
1991-08-27 |
Rutgers, The State University Of New Jersey |
Iontotherapeutic device and process and iontotherapeutic unit dose
|
ES2053549T3
(es)
|
1986-08-11 |
1994-08-01 |
Innovata Biomed Ltd |
Un proceso para la preparacion de una formulacion farmaceutica apropiada para inhalacion.
|
USRE35862E
(en)
*
|
1986-08-18 |
1998-07-28 |
Emisphere Technologies, Inc. |
Delivery systems for pharmacological agents encapsulated with proteinoids
|
WO1988001213A1
(en)
*
|
1986-08-18 |
1988-02-25 |
Clinical Technologies Associates, Inc. |
Delivery systems for pharmacological agents
|
ATE76311T1
(de)
*
|
1986-08-19 |
1992-06-15 |
Genentech Inc |
Einrichtung und dispersion zum intrapulmonalen eingeben von polypeptidwuchsstoffen und zytokinen.
|
NO162160C
(no)
|
1987-01-09 |
1989-11-15 |
Medi Cult As |
Serumfritt vekstmedium, samt anvendelse derav.
|
US4861627A
(en)
*
|
1987-05-01 |
1989-08-29 |
Massachusetts Institute Of Technology |
Preparation of multiwall polymeric microcapsules
|
GB8723846D0
(en)
*
|
1987-10-10 |
1987-11-11 |
Danbiosyst Ltd |
Bioadhesive microsphere drug delivery system
|
EP0360340A1
(en)
|
1988-09-19 |
1990-03-28 |
Akzo N.V. |
Composition for nasal administration containing a peptide
|
JPH02104531A
(ja)
|
1988-10-14 |
1990-04-17 |
Toyo Jozo Co Ltd |
経鼻投与用生理活性ペプチド組成物
|
US5006343A
(en)
*
|
1988-12-29 |
1991-04-09 |
Benson Bradley J |
Pulmonary administration of pharmaceutically active substances
|
US5514646A
(en)
*
|
1989-02-09 |
1996-05-07 |
Chance; Ronald E. |
Insulin analogs modified at position 29 of the B chain
|
CA2030551C
(en)
|
1989-05-01 |
1998-08-25 |
Wayne Gombotz |
Process for producing small particles of biologically active molecules
|
GB8921222D0
(en)
|
1989-09-20 |
1989-11-08 |
Riker Laboratories Inc |
Medicinal aerosol formulations
|
US5188837A
(en)
*
|
1989-11-13 |
1993-02-23 |
Nova Pharmaceutical Corporation |
Lipsopheres for controlled delivery of substances
|
DE3942145A1
(de)
|
1989-12-20 |
1991-06-27 |
Boehringer Mannheim Gmbh |
T-pa-solubilisierung
|
GB9001635D0
(en)
|
1990-01-24 |
1990-03-21 |
Ganderton David |
Aerosol carriers
|
WO1991016882A1
(en)
|
1990-05-08 |
1991-11-14 |
Liposome Technology, Inc. |
Direct spray-dried drug/lipid powder composition
|
US6331318B1
(en)
|
1994-09-30 |
2001-12-18 |
Emisphere Technologies Inc. |
Carbon-substituted diketopiperazine delivery systems
|
US5693338A
(en)
|
1994-09-29 |
1997-12-02 |
Emisphere Technologies, Inc. |
Diketopiperazine-based delivery systems
|
SE9002895D0
(sv)
|
1990-09-12 |
1990-09-12 |
Astra Ab |
Inhalation devices for dispensing powders i
|
IL99699A
(en)
*
|
1990-10-10 |
2002-04-21 |
Autoimmune Inc |
Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
|
GB9024760D0
(en)
|
1990-11-14 |
1991-01-02 |
Riker Laboratories Inc |
Inhalation device and medicament carrier
|
US5145684A
(en)
*
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
WO1992014449A1
(en)
*
|
1991-02-20 |
1992-09-03 |
Nova Pharmaceutical Corporation |
Controlled release microparticulate delivery system for proteins
|
US5492112A
(en)
*
|
1991-05-20 |
1996-02-20 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
CA2070061C
(en)
*
|
1991-06-07 |
2004-02-10 |
Shigeyuki Takama |
Physiologically active polypeptide-containing pharmaceutical composition
|
ES2141108T3
(es)
|
1991-07-02 |
2000-03-16 |
Inhale Inc |
Metodo y dispositivo para proporcionar medicamentos en aerosol.
|
GB9116610D0
(en)
|
1991-08-01 |
1991-09-18 |
Danbiosyst Uk |
Preparation of microparticles
|
US6063910A
(en)
*
|
1991-11-14 |
2000-05-16 |
The Trustees Of Princeton University |
Preparation of protein microparticles by supercritical fluid precipitation
|
US5329976A
(en)
*
|
1991-12-09 |
1994-07-19 |
Habley Medical Technology Corporation |
Syringe-filling and medication mixing dispenser
|
JP3121080B2
(ja)
*
|
1991-12-19 |
2000-12-25 |
アール・ピー・シーラー コーポレイション |
カプセル封入用溶液
|
DE69306755T2
(de)
|
1992-01-21 |
1997-04-10 |
Stanford Res Inst Int |
Verbessertes verfahren zur herstellung von mikronisierter polypeptidarzneimitteln
|
EP0558879B1
(en)
|
1992-03-04 |
1997-05-14 |
Astra Aktiebolag |
Disposable inhaler
|
US5352461A
(en)
|
1992-03-11 |
1994-10-04 |
Pharmaceutical Discovery Corporation |
Self assembling diketopiperazine drug delivery system
|
CA2115444C
(en)
|
1992-06-12 |
2000-10-03 |
Yuji Makino |
Preparation for intratracheobronchial administration
|
GB9213874D0
(en)
|
1992-06-30 |
1992-08-12 |
Fisons Plc |
Process to novel medicament form
|
US6582728B1
(en)
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
US5785049A
(en)
*
|
1994-09-21 |
1998-07-28 |
Inhale Therapeutic Systems |
Method and apparatus for dispersion of dry powder medicaments
|
BR9307270A
(pt)
|
1992-10-19 |
1999-06-01 |
Dura Pharma Inc |
Inalador de pó seco
|
US5888477A
(en)
*
|
1993-01-29 |
1999-03-30 |
Aradigm Corporation |
Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin
|
US5364838A
(en)
|
1993-01-29 |
1994-11-15 |
Miris Medical Corporation |
Method of administration of insulin
|
TW402506B
(en)
*
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
IS1796B
(is)
*
|
1993-06-24 |
2001-12-31 |
Ab Astra |
Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
|
US5747445A
(en)
*
|
1993-06-24 |
1998-05-05 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
US5562909A
(en)
|
1993-07-12 |
1996-10-08 |
Massachusetts Institute Of Technology |
Phosphazene polyelectrolytes as immunoadjuvants
|
EP0804174A4
(en)
*
|
1993-07-21 |
1998-09-09 |
Univ Kentucky Res Found |
MULTI-CHAMBER HARD CAPSULES WITH CONTROLLED DELIVERY CHARACTERISTICS
|
US5534488A
(en)
*
|
1993-08-13 |
1996-07-09 |
Eli Lilly And Company |
Insulin formulation
|
KR100310122B1
(ko)
*
|
1993-09-17 |
2002-04-24 |
한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 |
아실화된인슐린
|
GB9322014D0
(en)
|
1993-10-26 |
1993-12-15 |
Co Ordinated Drug Dev |
Improvements in and relating to carrier particles for use in dry powder inhalers
|
EP0655237A1
(de)
|
1993-11-27 |
1995-05-31 |
Hoechst Aktiengesellschaft |
Medizinische Aerosolformulierung
|
US5484606A
(en)
*
|
1994-01-24 |
1996-01-16 |
The Procter & Gamble Company |
Process for reducing the precipitation of difficulty soluble pharmaceutical actives
|
PL179443B1
(pl)
|
1994-03-07 |
2000-09-29 |
Inhale Therapeutic Syst |
Kompozycja insuliny, sposób wytwarzania kompozycji insuliny i sposób wytwarzania dawki insuliny w postaci aerozolu PL PL PL PL
|
US6051256A
(en)
*
|
1994-03-07 |
2000-04-18 |
Inhale Therapeutic Systems |
Dispersible macromolecule compositions and methods for their preparation and use
|
US6395744B1
(en)
*
|
1994-04-22 |
2002-05-28 |
Queen's University At Kingston |
Method and compositions for the treatment or amelioration of female sexual dysfunction
|
AU2517095A
(en)
|
1994-05-19 |
1995-12-18 |
R.P. Scherer International Corporation |
Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions
|
IL110024A
(en)
|
1994-06-15 |
1998-04-05 |
Yissum Res Dev Co |
Controlled release oral drug delivery system containing hydrogel- forming polymer
|
US5474978A
(en)
|
1994-06-16 |
1995-12-12 |
Eli Lilly And Company |
Insulin analog formulations
|
US5461031A
(en)
*
|
1994-06-16 |
1995-10-24 |
Eli Lilly And Company |
Monomeric insulin analog formulations
|
US5547929A
(en)
|
1994-09-12 |
1996-08-20 |
Eli Lilly And Company |
Insulin analog formulations
|
AU691361B2
(en)
*
|
1994-12-01 |
1998-05-14 |
Toyama Chemical Co. Ltd. |
Novel 2,3-diketopiperazine derivative or salt thereof
|
US5901703A
(en)
*
|
1995-02-06 |
1999-05-11 |
Unisia Jecs Corporation |
Medicine administering device for nasal cavities
|
US5653961A
(en)
*
|
1995-03-31 |
1997-08-05 |
Minnesota Mining And Manufacturing Company |
Butixocort aerosol formulations in hydrofluorocarbon propellant
|
US6258341B1
(en)
|
1995-04-14 |
2001-07-10 |
Inhale Therapeutic Systems, Inc. |
Stable glassy state powder formulations
|
US6428771B1
(en)
*
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
US5653987A
(en)
*
|
1995-05-16 |
1997-08-05 |
Modi; Pankaj |
Liquid formulations for proteinic pharmaceuticals
|
US5849322A
(en)
|
1995-10-23 |
1998-12-15 |
Theratech, Inc. |
Compositions and methods for buccal delivery of pharmaceutical agents
|
US5766620A
(en)
|
1995-10-23 |
1998-06-16 |
Theratech, Inc. |
Buccal delivery of glucagon-like insulinotropic peptides
|
CA2236579C
(en)
*
|
1995-11-13 |
2009-06-30 |
Minimed, Inc. |
Methods and compositions for the delivery of monomeric proteins
|
DE19545257A1
(de)
*
|
1995-11-24 |
1997-06-19 |
Schering Ag |
Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
|
US5912014A
(en)
|
1996-03-15 |
1999-06-15 |
Unigene Laboratories, Inc. |
Oral salmon calcitonin pharmaceutical products
|
FR2746035B1
(fr)
*
|
1996-03-15 |
1998-06-12 |
|
Microparticules de gel composite susceptibles d'etre utilisees comme vecteur(s) de principe(s) actif(s), l'un de leurs procedes de preparation et leurs applications
|
USRE37053E1
(en)
*
|
1996-05-24 |
2001-02-13 |
Massachusetts Institute Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
US5985309A
(en)
|
1996-05-24 |
1999-11-16 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
US6254854B1
(en)
*
|
1996-05-24 |
2001-07-03 |
The Penn Research Foundation |
Porous particles for deep lung delivery
|
US6503480B1
(en)
*
|
1997-05-23 |
2003-01-07 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
AUPO066096A0
(en)
|
1996-06-26 |
1996-07-18 |
Peptide Delivery Systems Pty Ltd |
Oral delivery of peptides
|
US5783556A
(en)
*
|
1996-08-13 |
1998-07-21 |
Genentech, Inc. |
Formulated insulin-containing composition
|
US6410511B2
(en)
|
1997-01-08 |
2002-06-25 |
Amylin Pharmaceuticals, Inc. |
Formulations for amylin agonist peptides
|
US7312196B2
(en)
|
1997-01-08 |
2007-12-25 |
Amylin Pharmaceuticals, Inc. |
Formulations for amylin agonist peptides
|
US6310038B1
(en)
|
1997-03-20 |
2001-10-30 |
Novo Nordisk A/S |
Pulmonary insulin crystals
|
EP0971729B1
(en)
|
1997-03-20 |
2002-07-03 |
Novo Nordisk A/S |
Therapeutic powder formulation for pulmonary administration, containing crystalline insulin
|
WO1998042367A1
(en)
|
1997-03-20 |
1998-10-01 |
Novo Nordisk A/S |
Method for preparation of a therapeutic powder through coprecipitation of insulin and absorption enhancer
|
US5898028A
(en)
*
|
1997-03-20 |
1999-04-27 |
Novo Nordisk A/S |
Method for producing powder formulation comprising an insulin
|
EP1627642A3
(en)
|
1997-03-20 |
2006-04-19 |
Novo Nordisk A/S |
Zinc free insulin crystals for use in pulmonary compositions
|
US6165484A
(en)
|
1997-08-26 |
2000-12-26 |
Wake Forest University |
EDTA and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections
|
EP1029536B1
(en)
*
|
1997-10-01 |
2007-11-28 |
Novadel Pharma Inc. |
Buccal non-polar spray
|
JP2002500196A
(ja)
|
1998-01-09 |
2002-01-08 |
ノヴォ ノルディスク アクティーゼルスカブ |
安定化させたインスリン組成物
|
JP2002511399A
(ja)
|
1998-04-09 |
2002-04-16 |
セラニーズ ベンチャーズ ゲー・エム・ベー・ハー |
肺投与のための粒状賦形剤
|
US6552024B1
(en)
*
|
1999-01-21 |
2003-04-22 |
Lavipharm Laboratories Inc. |
Compositions and methods for mucosal delivery
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
CA2367131C
(en)
*
|
1999-04-05 |
2007-07-03 |
Solomon S. Steiner |
Methods for fine powder formation
|
US7169889B1
(en)
*
|
1999-06-19 |
2007-01-30 |
Biocon Limited |
Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
|
PT1196430E
(pt)
|
1999-06-29 |
2012-04-18 |
Mannkind Corp |
Purificação e estabilização de péptidos e proteínas em agentes farmacêuticos
|
US7464706B2
(en)
|
1999-07-23 |
2008-12-16 |
Mannkind Corporation |
Unit dose cartridge and dry powder inhaler
|
EP1200149B1
(en)
|
1999-07-23 |
2006-09-20 |
MannKind Corporation |
Dry powder inhaler
|
US6264981B1
(en)
*
|
1999-10-27 |
2001-07-24 |
Anesta Corporation |
Oral transmucosal drug dosage using solid solution
|
NZ518401A
(en)
*
|
1999-10-29 |
2004-01-30 |
Nektar Therapeutics |
Dry powder compositions having improved dispersivity
|
US6465425B1
(en)
|
2000-02-10 |
2002-10-15 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
|
CN100341483C
(zh)
*
|
2000-02-28 |
2007-10-10 |
维克丘拉有限公司 |
口服药物输递中或涉及口服药物输递的改进
|
US6432383B1
(en)
*
|
2000-03-30 |
2002-08-13 |
Generex Pharmaceuticals Incorporated |
Method for administering insulin
|
US7316999B2
(en)
|
2000-06-02 |
2008-01-08 |
Novo Nordisk A/S |
Glucose dependent release of insulin from glucose sensing insulin derivatives
|
CN1141974C
(zh)
|
2000-06-07 |
2004-03-17 |
张昊 |
结肠定位释放的口服生物制剂
|
CA2774959C
(en)
|
2000-08-04 |
2016-05-31 |
Dmi Biosciences, Inc. |
Method of using diketopiperazines and composition containing them
|
JP4147234B2
(ja)
|
2004-09-27 |
2008-09-10 |
キヤノン株式会社 |
吐出用液体、吐出方法、カートリッジ及び吐出装置
|
DE10114178A1
(de)
*
|
2001-03-23 |
2002-10-10 |
Aventis Pharma Gmbh |
Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
|
JP2005508220A
(ja)
|
2001-10-24 |
2005-03-31 |
パーリ・ゲーエムベーハー |
薬用組成物調製用具
|
US20030198666A1
(en)
|
2002-01-07 |
2003-10-23 |
Richat Abbas |
Oral insulin therapy
|
US20030143195A1
(en)
*
|
2002-01-30 |
2003-07-31 |
Pinsker Judy Senior |
Use of histamine as a drug delivery enhancing compound for use in transmucosal or transdermal delivery
|
US7255102B2
(en)
*
|
2002-02-01 |
2007-08-14 |
Generex Pharmaceuticals Inc. |
Metered dose spray device for use with macromolecular pharmaceutical agents such as insulin
|
EP1490031A1
(en)
*
|
2002-03-07 |
2004-12-29 |
Vectura Limited |
Fast melt multiparticulate formulations for oral delivery
|
US20030194420A1
(en)
|
2002-04-11 |
2003-10-16 |
Richard Holl |
Process for loading a drug delivery device
|
JP2005526126A
(ja)
*
|
2002-05-07 |
2005-09-02 |
ノボ ノルディスク アクティーゼルスカブ |
インスリンアスパルト及びインスリンデテミアを含む可溶性製剤
|
DE10227232A1
(de)
*
|
2002-06-18 |
2004-01-15 |
Aventis Pharma Deutschland Gmbh |
Saure Insulinzubereitungen mit verbesserter Stabilität
|
DE10235168A1
(de)
*
|
2002-08-01 |
2004-02-12 |
Aventis Pharma Deutschland Gmbh |
Verfahren zur Reinigung von Preproinsulin
|
JP2006512409A
(ja)
*
|
2002-10-31 |
2006-04-13 |
ユーエムディー, インコーポレイテッド |
薬物送達用治療組成物で被覆上皮に対するもの及びそれを介するもの
|
CA2510199A1
(en)
|
2002-12-17 |
2004-07-08 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for enhanced mucosal delivery of y2 receptor-binding peptides and methods for treating and preventing obesity
|
JP2006514119A
(ja)
*
|
2003-02-12 |
2006-04-27 |
アール アンド ピー コリア カンパニー リミテッド |
溶解率が向上した難溶性薬剤の溶媒系
|
US20040171518A1
(en)
|
2003-02-27 |
2004-09-02 |
Medtronic Minimed, Inc. |
Compounds for protein stabilization and methods for their use
|
WO2004080401A2
(en)
|
2003-03-06 |
2004-09-23 |
Emisphere Technologies, Inc. |
Oral insulin therapies and protocol
|
US20050203001A1
(en)
|
2004-03-05 |
2005-09-15 |
Emisphere Technologies, Inc. |
Oral insulin therapies and protocol
|
BRPI0414539B8
(pt)
*
|
2003-09-19 |
2021-05-25 |
Novo Nordisk As |
composto, composição farmacêutica, e, uso de um composto
|
US7192919B2
(en)
*
|
2004-01-07 |
2007-03-20 |
Stelios Tzannis |
Sustained release compositions for delivery of pharmaceutical proteins
|
KR100985126B1
(ko)
*
|
2004-01-12 |
2010-10-05 |
맨카인드 코포레이션 |
제2형 당뇨병에서 혈청 프로인슐린 수치의 감소 방법
|
US8048454B2
(en)
*
|
2004-03-09 |
2011-11-01 |
Michael Martin |
Methods and compositions related to regulation of cytokine production by glycogen synthase kinase 3 (GSK-3)
|
US20080090753A1
(en)
*
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
US20080096800A1
(en)
*
|
2004-03-12 |
2008-04-24 |
Biodel, Inc. |
Rapid mucosal gel or film insulin compositions
|
US20080085298A1
(en)
*
|
2004-03-12 |
2008-04-10 |
Biodel, Inc. |
Rapid Mucosal Gel or Film Insulin Compositions
|
AU2005222613B2
(en)
|
2004-03-12 |
2009-12-17 |
Biodel, Inc. |
Rapid acting drug delivery compositions
|
WO2006088473A2
(en)
|
2004-04-23 |
2006-08-24 |
Panduranga Rao Koritala |
Microcapsules and nanocapsules for the transmucosal delivery of therapeutic and diagnostic agents
|
US7964012B2
(en)
*
|
2005-08-03 |
2011-06-21 |
Hollingsworth & Vose Company |
Filter media with improved conductivity
|
US8084420B2
(en)
*
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US7713929B2
(en)
*
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US20070086952A1
(en)
*
|
2005-09-29 |
2007-04-19 |
Biodel, Inc. |
Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
|
WO2007047948A2
(en)
|
2005-10-20 |
2007-04-26 |
Nastech Pharmaceutical Company Inc. |
Intranasal administration of rapid acting insulin
|
EP1962882A4
(en)
*
|
2005-11-22 |
2010-01-06 |
Dia B Tech Ltd |
COMPOSITIONS AND METHOD FOR TREATING DIABETES
|
US8093207B2
(en)
*
|
2005-12-09 |
2012-01-10 |
Unigene Laboratories, Inc. |
Fast-acting oral peptide pharmaceutical products
|
FR2896164B1
(fr)
*
|
2006-01-18 |
2008-07-04 |
Flamel Technologies Sa |
Formulation colloidale d'insuline longue action et sa preparation
|
CA2649109A1
(en)
|
2006-04-12 |
2007-10-25 |
Biodel, Inc. |
Rapid acting and long acting insulin combination formulations
|
US8084022B2
(en)
|
2006-06-23 |
2011-12-27 |
Aegis Therapeutics, Llc |
Stabilizing alkylglycoside compositions and methods thereof
|
WO2008013955A2
(en)
|
2006-07-27 |
2008-01-31 |
Nektar Therapeutics |
Sustained release formulations for pulmonary delivery
|
CA2660029A1
(en)
|
2006-08-04 |
2008-02-07 |
Nastech Pharmaceutical Company Inc. |
Compositions for intranasal delivery of human insulin and uses thereof
|
GB0700523D0
(en)
|
2007-01-11 |
2007-02-21 |
Insense Ltd |
The Stabilisation Of Proteins
|
ES2744384T3
(es)
|
2007-06-13 |
2020-02-24 |
Novo Nordisk As |
Formulación farmacéutica que comprende un derivado de insulina
|
AU2009204309B2
(en)
*
|
2008-01-04 |
2012-11-22 |
Biodel, Inc. |
Insulin formulations for insulin release as a function of tissue glucose levels
|
TWI394580B
(zh)
*
|
2008-04-28 |
2013-05-01 |
Halozyme Inc |
超快起作用胰島素組成物
|
US9060927B2
(en)
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
PL2340033T3
(pl)
|
2009-06-26 |
2014-03-31 |
Novo Nordisk As |
Preparat zawierający insulinę, nikotynamid i argininę
|